Related Experiment Video

Updated: Aug 23, 2026

Quantitative 3D In Silico Modeling (q3DISM) of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
09:33

Quantitative 3D In Silico Modeling (q3DISM) of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

Published on: December 26, 2016

Microglia and Alzheimer's disease pathogenesis

Wolfgang J Streit1

  • 1Department of Neuroscience, University of Florida College of Medicine, Gainesville, Florida 32610-0244, USA. streit@mbi.ufl.edu

Journal of Neuroscience Research
|June 16, 2004
PubMed

Insights

This review critically examines the neuroinflammation hypothesis in Alzheimer's disease (AD), proposing microglial dysfunction as an alternative theory. It explores the evolving role of microglia in AD pathogenesis, considering recent biological insights.

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • Microglial cells are implicated in Alzheimer's disease (AD) pathogenesis.
  • The dominant hypothesis suggests activated microglia cause neurodegeneration via neuroinflammation.
  • This concept is expanding to other neurodegenerative diseases.

Purpose of the Study:

  • To critically review evidence supporting the neuroinflammation hypothesis in AD.
  • To explore an alternative theory: microglial dysfunction in AD pathogenesis.
  • To integrate recent findings in microglial biology into AD research.

Main Methods:

  • Comprehensive literature review and critical analysis of existing evidence.
  • Examination of studies on microglial cell activation and function in AD.
  • Synthesis of data from basic microglial biology research.

Main Results:

  • The neuroinflammation hypothesis, while influential, has weaknesses.
  • The microglial dysfunction hypothesis offers an alternative perspective.
  • This alternative theory aligns with recent advances in understanding microglial biology.

Conclusions:

  • The role of microglia in AD is complex and requires further investigation.
  • Microglial dysfunction presents a viable alternative or complementary theory to neuroinflammation in AD.
  • Understanding microglial biology is crucial for unraveling AD pathogenesis.

More Related Videos

Rapid and Refined CD11b Magnetic Isolation of Primary Microglia with Enhanced Purity and Versatility07:54

Rapid and Refined CD11b Magnetic Isolation of Primary Microglia with Enhanced Purity and Versatility

Published on: April 13, 2017

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates09:12

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates

Published on: January 30, 2014

Related Concept Videos

Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...